论文部分内容阅读
异噁噻酰胺(Isoxicam)是迄今为止,比现代市场上所有抗风湿非类固醇抗炎药物更为有效的新药,而其耐受性与其它药物同样良好。其特点为半排出期平均为31小时,使本药最适于每日服1次,而且对青年或老年,甚至具有肝、肾功能不全者,在药效学方面没有显著性差异。药物在体内的有效浓度持久而稳定,曾用安慰剂代替异噁噻酰胺服用48小时后,亦不见疼痛加剧,提示在本药服用期间,偶而停服1～2天,也不至影响疗效。用单剂量200mg治疗类风湿关节炎后3小时;或用单剂量400mg治疗急性痛风后2
Isoxicam is by far more effective than all other anti-rheumatic and non-steroidal anti-inflammatory drugs on the modern market, and its tolerance is as good as that of other drugs. It is characterized by half an average of 31 hours of discharge, the most suitable for the drug once daily service, but also for young or old, and even liver and kidney dysfunction, there is no significant difference in pharmacodynamics. The effective concentration of drugs in the body lasting and stable, placebo was used in place of isothiazamide 48 hours after the pain was not seen, suggesting that during the period of taking this drug, and occasionally stop taking 1 to 2 days, nor does it affect the efficacy. A single dose of 200mg after treatment of rheumatoid arthritis 3 hours; or a single dose of 400mg after treatment of acute gout 2